In the last 2 years rates of TB in the UK have increased dramatically, including in traditionally low-incidence regions. The overall TB notification rate for England rose from 8·5 notifications to 9·5 notifications per 100 000 people between 2023 and 2024 (ie, England only just remains below the threshold of 10 notifications per 100 000 people for WHO low-incidence country status).
The current global TB diagnostics standard is to apply molecular diagnostics, typically PCR-derived methods, routinely to sputum and similar pulmonary samples. The National Institute for Health and Care Excellence (NICE) TB guidelines from 2016–2017 recommended rapid diagnostic testing.
A correspondence, published in The Lancet, comments on the failure to apply rapid molecular diagnostic tools to patient specimens routinely in the UK, and emphasizes the urgency for NICE to reinforce this crucial global TB diagnostic message.
For more TB updates, check out the TB CAB Weekly Newsletter (Issue #27, 30 August 2025).
The newsletter is brought to you by the Global TB Community Advisory Board (TB CAB) with the support of Treatment Action Group (TAG) and EATG. Subscribe to the newsletter here.
Source : The Lancet
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.